Lateral Flow Assay Components Market Size to grow by USD 97.76 million between 2023-2027
According to a research report “ Lateral Flow Assay Components Market” by End-user (Medical device manufacturing companies, Medical device contract manufacturing companies) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2027 published by Technavio, the market size is estimated to grow by USD 97.76 million, at a CAGR of 5.22% during the forecast period. The lateral flow assay components market is poised for significant growth due to the increasing focus on research and development for diagnosing and treating rare diseases such as salmonella and malaria. The urgency for early diagnosis and the approval of rapid lateral flow tests during the COVID-19 pandemic further accentuates market demand. Additionally, the global prevalence of infectious diseases, an aging population, and the availability of home-based lateral flow assay kits are anticipated to fuel market expansion. These factors create substantial opportunities for manufacturers in the lateral flow assay components industry.
Browse market data tables, figures, and in-depth TOC on “Lateral Flow Assay Components Market” by End-user (Medical device manufacturing companies, Medical device contract manufacturing companies) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2027. Download Free Sample
By End-user, the Medical device manufacturing companies segment is projected to dominate the market size in 2024
ai_market_segmentation_by
By Geography, North America segment is expected to hold the largest market size for the year 2024
The Lateral Flow Assay (LFA) market encompasses technologies that utilize the sandwich assay technique for detecting target antigens in various samples. This method involves the use of two antibodies: a capture antibody, which is immobilized on a solid support, and a detection antibody. The antigen of interest is sandwiched between these antibodies, resulting in a positive test outcome denoted by the appearance of a colored line at the test line position. The sandwich assay's efficiency and accuracy make it an indispensable tool in industries such as diagnostics, food testing, and environmental monitoring.
North America is forecasted to hold the largest market size by region in 2024
The lateral flow assay components market in North America holds a significant market share, driven by the region's advanced healthcare system and increasing incidence of chronic diseases such as Lyme disease and tuberculosis. According to the US Centers for Disease Control and Prevention (CDC), approximately 16 million influenza infections occurred in the US in 2020, resulting in an estimated 380,000 hospitalizations. This underscores the importance of diagnostic tools like lateral flow assays in managing infectious diseases. Major vendors are capitalizing on this trend by focusing on the US market to expand their market presence and meet the growing demand for diagnostic solutions. The adoption of advanced PCR diagnostic technologies has also fueled the need for regular testing and medical check-ups, further boosting the market growth in North America.
The Lateral Flow Assay Components Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Lateral Flow Assay (LFA) components market encompasses a wide range of applications, including the testing for various infectious diseases such as Hepatitis and Influenza, as well as cardiac marker testing. In the healthcare sector, LFAs are increasingly being used for rapid diagnosis in areas like pregnancy and infectious diseases. The veterinary sector also utilizes LFA technology for the detection of animal diseases. ELISA tests and Rapid Antigen testing are conventional substitutes that LFAs are replacing due to their simplified manner and faster results. LFAs use probes, such as DNA or antibodies, to detect specific biomarkers, making them an effective diagnostic technique in various industries. The food and beverage industry uses LFAs for pathogen detection, while the healthcare industry benefits from their use in cardiovascular diseases and geriatric population diagnosis. Home-based devices are a growing trend in the LFA components market, making diagnostic testing more accessible and convenient for individuals.
Market Research Overview
The Lateral Flow Assay (LFA) Components Market encompasses a wide range of applications, including fertility testing, pregnancy testing, myoglobin testing, syphilis testing, gonorrhoea testing, chlamydia testing, HPV testing, HIV testing, tuberculosis, hepatitis, influenza testing, cardiac marker testing, and more. This diagnostic technique is popular due to its simplified manner, rapid analysis time, and portability. LFA components include absorbent pads, conjugate pads, sample pads, membranes, and nitrocellulose membranes. These pads and membranes are used in various diagnostic applications, such as ELISA tests, rapid antigen testing, and multiplex detection assays. The market for LFA components caters to various sectors, including healthcare, food and beverage, veterinary, and environmental testing. LFA components are used in the detection of biomarkers for chronic diseases like HIV, cardiovascular diseases, and infectious diseases. They are also used in home-based devices and in the diagnosis of behavioral health conditions, such as saliva diagnostics. The market for LFA components is expanding to include applications in animal health, food safety, drug testing, and biowarfare. The shelf life, pore size, and cross reactivity of LFA components are crucial factors that affect their performance. The use of probes and antibodies in LFA components enhances their affinity and specificity for biomolecules. The market for LFA components is expected to grow due to the increasing demand for rapid diagnosis, portability, and cost-effective testing in various sectors.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
